These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 28405672

  • 21. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
    Russo I, Del Mese P, Doronzo G, Mattiello L, Viretto M, Bosia A, Anfossi G, Trovati M.
    Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
    [Abstract] [Full Text] [Related]

  • 22. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
    Li Z, Ajdic J, Eigenthaler M, Du X.
    Blood; 2003 Jun 01; 101(11):4423-9. PubMed ID: 12576312
    [Abstract] [Full Text] [Related]

  • 23. The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro.
    Bregenholt S, Møldrup A, Blume N, Karlsen AE, Nissen Friedrichsen B, Tornhave D, Knudsen LB, Petersen JS.
    Biochem Biophys Res Commun; 2005 May 06; 330(2):577-84. PubMed ID: 15796922
    [Abstract] [Full Text] [Related]

  • 24. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
    Chang CC, Lu WJ, Chiang CW, Jayakumar T, Ong ET, Hsiao G, Fong TH, Chou DS, Sheu JR.
    J Nutr Biochem; 2010 Dec 06; 21(12):1214-21. PubMed ID: 20015631
    [Abstract] [Full Text] [Related]

  • 25. Exendin-4 inhibits structural remodeling and improves Ca2+ homeostasis in rats with heart failure via the GLP-1 receptor through the eNOS/cGMP/PKG pathway.
    Chen J, Wang D, Wang F, Shi S, Chen Y, Yang B, Tang Y, Huang C.
    Peptides; 2017 Apr 06; 90():69-77. PubMed ID: 28242257
    [Abstract] [Full Text] [Related]

  • 26. β cell membrane remodelling and procoagulant events occur in inflammation-driven insulin impairment: a GLP-1 receptor dependent and independent control.
    Gleizes C, Kreutter G, Abbas M, Kassem M, Constantinescu AA, Boisramé-Helms J, Yver B, Toti F, Kessler L.
    J Cell Mol Med; 2016 Feb 06; 20(2):231-42. PubMed ID: 26607759
    [Abstract] [Full Text] [Related]

  • 27. A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells.
    Hattori Y, Jojima T, Tomizawa A, Satoh H, Hattori S, Kasai K, Hayashi T.
    Diabetologia; 2010 Oct 06; 53(10):2256-63. PubMed ID: 20593161
    [Abstract] [Full Text] [Related]

  • 28. Platelet nitric oxide signalling in heart failure: role of oxidative stress.
    Shah A, Passacquale G, Gkaliagkousi E, Ritter J, Ferro A.
    Cardiovasc Res; 2011 Sep 01; 91(4):625-31. PubMed ID: 21502370
    [Abstract] [Full Text] [Related]

  • 29. Natriuretic peptides induce weak VASP phosphorylation at Serine 239 in platelets.
    Borgognone A, Lowe KL, Watson SP, Madhani M.
    Platelets; 2014 Sep 01; 25(1):1-7. PubMed ID: 23469931
    [Abstract] [Full Text] [Related]

  • 30. Synergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway.
    Ke J, Liu Y, Yang J, Lu R, Tian Q, Hou W, Wang G, Wei R, Hong T.
    Sci Rep; 2017 Feb 01; 7():41085. PubMed ID: 28145471
    [Abstract] [Full Text] [Related]

  • 31. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
    Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Silljé HH.
    Arterioscler Thromb Vasc Biol; 2010 Jul 01; 30(7):1407-14. PubMed ID: 20448207
    [Abstract] [Full Text] [Related]

  • 32. Antithrombotic activities of ferulic acid via intracellular cyclic nucleotide signaling.
    Hong Q, Ma ZC, Huang H, Wang YG, Tan HL, Xiao CR, Liang QD, Zhang HT, Gao Y.
    Eur J Pharmacol; 2016 Apr 15; 777():1-8. PubMed ID: 26948317
    [Abstract] [Full Text] [Related]

  • 33. Liraglutide Attenuates Myocardial Ischemia/Reperfusion Injury Through the Inhibition of Necroptosis by Activating GLP-1R/PI3K/Akt Pathway.
    Zhou G, Wu H, Yang J, Ye M, Liu D, Li Y, Zhang D, Zhang J, Yang Q, Liu Y.
    Cardiovasc Toxicol; 2023 Apr 15; 23(3-4):161-175. PubMed ID: 36934206
    [Abstract] [Full Text] [Related]

  • 34. Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.
    Helmstädter J, Frenis K, Filippou K, Grill A, Dib M, Kalinovic S, Pawelke F, Kus K, Kröller-Schön S, Oelze M, Chlopicki S, Schuppan D, Wenzel P, Ruf W, Drucker DJ, Münzel T, Daiber A, Steven S.
    Arterioscler Thromb Vasc Biol; 2020 Jan 15; 40(1):145-158. PubMed ID: 31747801
    [Abstract] [Full Text] [Related]

  • 35. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
    Ban K, Kim KH, Cho CK, Sauvé M, Diamandis EP, Backx PH, Drucker DJ, Husain M.
    Endocrinology; 2010 Apr 15; 151(4):1520-31. PubMed ID: 20172966
    [Abstract] [Full Text] [Related]

  • 36. Synergistic phosphorylation of the focal adhesion-associated vasodilator-stimulated phosphoprotein in intact human platelets in response to cGMP- and cAMP-elevating platelet inhibitors.
    Nolte C, Eigenthaler M, Horstrup K, Hönig-Liedl P, Walter U.
    Biochem Pharmacol; 1994 Oct 18; 48(8):1569-75. PubMed ID: 7980622
    [Abstract] [Full Text] [Related]

  • 37. The thrombin inhibitors hirudin and Refludan(®) activate the soluble guanylyl cyclase and the cGMP pathway in washed human platelets.
    Kobsar A, Koessler J, Kehrer L, Gambaryan S, Walter U.
    Thromb Haemost; 2012 Mar 18; 107(3):521-9. PubMed ID: 22234363
    [Abstract] [Full Text] [Related]

  • 38. Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress.
    Doronzo G, Viretto M, Russo I, Mattiello L, Di Martino L, Cavalot F, Anfossi G, Trovati M.
    Atherosclerosis; 2011 May 18; 216(1):44-53. PubMed ID: 21316056
    [Abstract] [Full Text] [Related]

  • 39. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure.
    Kim M, Platt MJ, Shibasaki T, Quaggin SE, Backx PH, Seino S, Simpson JA, Drucker DJ.
    Nat Med; 2013 May 18; 19(5):567-75. PubMed ID: 23542788
    [Abstract] [Full Text] [Related]

  • 40. Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner.
    Wei R, Ma S, Wang C, Ke J, Yang J, Li W, Liu Y, Hou W, Feng X, Wang G, Hong T.
    Am J Physiol Endocrinol Metab; 2016 Jun 01; 310(11):E947-57. PubMed ID: 27072494
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.